NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients

NCT04353973

CompletedNA

Sponsor: Abramson Cancer Center at Penn Medicine

Conditions: Cancer

Interventions: Pre-Test Intervention, Standard of Care, Post-Test Intervention

Countries: United States

This study aims to determine if web-based eHealth delivery of pre-test and/or post-test counseling in cancer patients and/or those at risk for cancer can provide equal or improved cognitive and affective outcomes when compared to the standard of care delivery model.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* 18 years of age or older
* Speak and understand English
* Male or Female
* A personal history of one or more of the following:

  * metastatic breast cancer
  * advanced ovarian cancer (Stage III-IV)
  * metastatic pancreatic cancer
  * metastatic prostate cancer
* Naive to previous cancer germline genetic testing

Exclusion Criteria:

* Communication difficulties such as:

  * Uncorrected or uncompensated hearing and/or vision impairment
  * Uncorrected or uncompensated speech defects
  * Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and tasks

Locations (1)

Philadelphia, Pennsylvania, United States